Seres Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Seres Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Seres Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $82.9M, a 23.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $82.9M -$25.2M -23.3% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $103M -$7M -6.35% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $106M -$3.25M -2.98% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $90.4M -$20.6M -18.5% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $108M +$84.4M +355% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $110M +$85.3M +341% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $109M +$82.7M +315% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $111M +$92.8M +510% Dec 31, 2022 8-K 2024-08-15
Q3 2022 $23.7M +$12.2M +105% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $25M +$12.6M +101% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $26.2M +$17.9M +213% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $18.2M +$9.17M +101% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $11.6M +$1.92M +19.9% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $12.4M +$2.16M +21% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $8.39M -$2.43M -22.5% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $9.04M -$2.32M -20.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $9.66M -$2.24M -18.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $10.3M -$2.38M -18.9% Jun 30, 2020 10-Q 2020-07-28
Q1 2020 $10.8M -$2.38M -18% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $11.4M Dec 31, 2019 10-K 2021-03-02
Q3 2019 $11.9M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $12.6M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $13.2M Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.